Literature DB >> 8443855

Hypertension and pulmonary oedema associated with ketamine administration in a patient with a history of substance abuse.

J L Murphy1.   

Abstract

Cocaine use, frequently associated with other substance abuse, is becoming more common in the pregnant patient. These patients are more likely to experience peripartum complications. A case of hypertension and pulmonary oedema in such a patient, possibly triggered by ketamine, is reported. A tumultuous course in the intensive care unit was resolved when the patient's hypertension and sympathetic reactivity were successfully treated with barbiturates. A number of factors supported a diagnosis of barbiturate withdrawal in this patient, its onset also was related temporally to ketamine administration. Hypertension should be considered a sign of acute barbiturate withdrawal. If a history of cocaine use, particularly crack cocaine, is elicited, one should suspect multiple substance abuse and be especially cautious when administering ketamine.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8443855     DOI: 10.1007/BF03011314

Source DB:  PubMed          Journal:  Can J Anaesth        ISSN: 0832-610X            Impact factor:   5.063


  21 in total

Review 1.  The problem of prenatal cocaine exposure. A rush to judgment.

Authors:  L C Mayes; R H Granger; M H Bornstein; B Zuckerman
Journal:  JAMA       Date:  1992-01-15       Impact factor: 56.272

2.  Validity of self-reporting of marijuana and cocaine use among pregnant adolescents.

Authors:  B Zuckerman; H Amaro; H Cabral
Journal:  J Pediatr       Date:  1989-11       Impact factor: 4.406

3.  Treatment of the barbiturate abstinence syndrome.

Authors:  J T Sullivan; E M Sellers
Journal:  Med J Aust       Date:  1986-11-03       Impact factor: 7.738

4.  [Induction of anaesthesia in patients with coronary artery disease: flunitrazepam, diazepam, ketamine, fentanyl. A haemodynamic study (author's transl)].

Authors:  J Tarnow; W Hess; D Schmidt; H J Eberlein
Journal:  Anaesthesist       Date:  1979-01       Impact factor: 1.041

5.  Pulmonary dysfunction in 'freebase' cocaine users.

Authors:  J Itkonen; S Schnoll; J Glassroth
Journal:  Arch Intern Med       Date:  1984-11

6.  [Pulmonary hypertension and pulmonary edema caused by intravenous ketamine (author's transl)].

Authors:  J Tarnow; W Hess
Journal:  Anaesthesist       Date:  1978-10       Impact factor: 1.041

7.  The pulmonary vascular lesions of intravenous drug abuse.

Authors:  J F Tomashefski; C S Hirsch
Journal:  Hum Pathol       Date:  1980-03       Impact factor: 3.466

Review 8.  Pulmonary oedema associated with airway obstruction.

Authors:  S A Lang; P G Duncan; D A Shephard; H C Ha
Journal:  Can J Anaesth       Date:  1990-03       Impact factor: 5.063

9.  Cocaine use during pregnancy: perinatal outcomes.

Authors:  A Handler; N Kistin; F Davis; C Ferré
Journal:  Am J Epidemiol       Date:  1991-04-15       Impact factor: 4.897

10.  Intravenous injection of talc-containing drugs intended for oral use. A cause of pulmonary granulomatosis and pulmonary hypertension.

Authors:  E N Arnett; W E Battle; J V Russo; W C Roberts
Journal:  Am J Med       Date:  1976-05-10       Impact factor: 4.965

View more
  5 in total

1.  Identifying and Addressing the Unmet Health Care Needs of Drug Court Clients.

Authors:  Karen L Dugosh; David S Festinger; Jessica L Lipkin
Journal:  J Subst Abuse Treat       Date:  2016-08-28

2.  Ketamine and pulmonary oedema-report of two cases.

Authors:  S Parthasarathy; M Ravishankar; S Selvarajan; T Anbalagan
Journal:  Indian J Anaesth       Date:  2009-08

Review 3.  Ketamine : from medicine to misuse.

Authors:  Kim Wolff; Adam R Winstock
Journal:  CNS Drugs       Date:  2006       Impact factor: 5.749

4.  Ketamine inhibits lung fluid clearance through reducing alveolar sodium transport.

Authors:  Yong Cui; Hongguang Nie; Hong Ma; Lei Chen; Lin Zhang; Junke Wang; Honglong Ji
Journal:  J Biomed Biotechnol       Date:  2011-10-03

5.  The epidemiology and patterns of acute and chronic toxicity associated with recreational ketamine use.

Authors:  Sarbjeet S Kalsi; David M Wood; Paul I Dargan
Journal:  Emerg Health Threats J       Date:  2011-04-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.